Schroder Investment Management Group’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-23,232
Closed -$206K 1363
2020
Q1
$206K Buy
23,232
+805
+4% +$6.78K ﹤0.01% 1103
2019
Q4
$219K Buy
22,427
+1,730
+8% +$16.2K ﹤0.01% 1152
2019
Q3
$196K Sell
20,697
-1,584
-7% -$16.7K ﹤0.01% 1152
2019
Q2
$265K Sell
22,281
-13,023
-37% -$157K ﹤0.01% 1055
2019
Q1
$622K Buy
35,304
+3,161
+10% +$52.6K ﹤0.01% 978
2018
Q4
$558 Sell
32,143
-3,693
-10% -$63K ﹤0.01% 983
2018
Q3
$534K Sell
35,836
-10,063
-22% -$156K ﹤0.01% 1018
2018
Q2
$732K Sell
45,899
-7,277
-14% -$109K ﹤0.01% 996
2018
Q1
$755K Buy
53,176
+4,229
+9% +$62.6K ﹤0.01% 999
2017
Q4
$685K Buy
48,947
+10,838
+28% +$159K ﹤0.01% 1046
2017
Q3
$541K Sell
38,109
-405,237
-91% -$5.79M ﹤0.01% 1059
2017
Q2
$7.05M Sell
443,346
-50,173
-10% -$723K 0.01% 674
2017
Q1
$6.74M Buy
493,519
+19,045
+4% +$266K 0.01% 669
2016
Q4
$8.4M Sell
474,474
-204,134
-30% -$3.59M 0.02% 647
2016
Q3
$13.1M Sell
678,608
-517,278
-43% -$10.1M 0.02% 566
2016
Q2
$23.3M Sell
1,195,886
-986,334
-45% -$19.3M 0.05% 426
2016
Q1
$46M Sell
2,182,220
-192,538
-8% -$3.79M 0.1% 265
2015
Q4
$48.7M Buy
2,374,758
+657,678
+38% +$12.6M 0.1% 254
2015
Q3
$29.4M Buy
1,717,080
+94,000
+6% +$1.72M 0.06% 359
2015
Q2
$29.9M Sell
1,623,080
-12,600
-0.8% -$234K 0.06% 385
2015
Q1
$31.3M Buy
1,635,680
+930,634
+132% +$17.2M 0.06% 369
2014
Q4
$11.6M Sell
705,046
-2,600
-0.4% -$44.6K 0.02% 607
2014
Q3
$12.5M Sell
707,646
-57,908
-8% -$1.14M 0.02% 616
2014
Q2
$15.8M Buy
765,554
+236,400
+45% +$4.86M 0.02% 544
2014
Q1
$11.5M Buy
529,154
+22,654
+4% +$519K 0.01% 597
2013
Q4
$13.4M Sell
506,500
-188,200
-27% -$4.63M 0.02% 573
2013
Q3
$16.4M Buy
694,700
+482,000
+227% +$11.3M 0.04% 491
2013
Q2
$4.57M Buy
+212,700
New +$4.59M 0.01% 772

Other funds holding VIVO

Schroder Investment Management Group's VIVO Position: Q2 2020 in Review

Schroder Investment Management Group sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 23,232 shares — an estimated $206K sold.

Schroder Investment Management Group first reported a position in VIVO in Q2 2013 and held it in 28 quarters. The position peaked at $48.7M in Q4 2015. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Schroder Investment Management Group reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 23,232 Meridian Bioscience Inc shares in Q2 2020, an estimated $206K.
  • Schroder Investment Management Group first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 28 quarters.
  • Schroder Investment Management Group's Meridian Bioscience Inc position peaked at $48.7M in Q4 2015.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Schroder Investment Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.